Antonio García-Hermoso, Jacinto Muñoz-Pardeza, Ignacio Hormazábal-Aguayo, Yasmin Ezzatvar
{"title":"Adults With Type 1 Diabetes Are Less Physically Active Than Adults Without Diabetes: A Systematic Review and Meta-Analysis","authors":"Antonio García-Hermoso, Jacinto Muñoz-Pardeza, Ignacio Hormazábal-Aguayo, Yasmin Ezzatvar","doi":"10.1002/dmrr.70250","DOIUrl":"10.1002/dmrr.70250","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>Physical activity is central to the management of type 1 diabetes, yet diabetes-specific barriers may reduce habitual activity. We systematically reviewed and meta-analysed studies comparing physical activity and sedentary behaviour in adults with type 1 diabetes and adults without diabetes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Material and Methods</h3>\u0000 \u0000 <p>MEDLINE, Embase, and SPORTDiscus were searched from inception to 24 July 2026. Random-effects models were used to pool standardised mean differences for continuous outcomes and odds ratios (OR) for meeting physical activity recommendations or study-defined active criteria.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixteen publications representing 14 independent cohorts and 3335 participants were included (54.2% females). Adults with type 1 diabetes had lower total physical activity than adults without diabetes (12 studies; Hedges <i>g</i> = −0.13; 95% confidence interval, −0.22 to −0.05; <i>p</i> = 0.001), with no detected heterogeneity. They also had lower estimated odds of meeting a physical activity criterion, although the association was not statistically significant (4 studies; OR = 0.77; 95% confidence interval, 0.58–1.02; <i>p</i> = 0.066). Mean age, diabetes duration and glycated haemoglobin were not associated with between-group differences in total physical activity. Data were insufficient to pool sedentary behaviour, steps or intensity-specific outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Adults with type 1 diabetes engage in slightly less total physical activity than adults without diabetes, although evidence regarding adherence to physical activity recommendations remains inconclusive. The absence of population-based studies limits the generalisability of these findings and highlights the need for representative studies using standardised device-based assessments.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 8","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70250","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149344210","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
G. Di Stasio, R. Colella, D. G. Armstrong, A. Bellingeri, A. De Mola, G. Montini, V. Scotti, A. De Silvestri, F. Campitiello
{"title":"Biomechanical Evolution in the Neuropathic Diabetic Foot: A Scoping Review of Gait and Kinetic-Kinematic-Structural Adaptations in Diabetes","authors":"G. Di Stasio, R. Colella, D. G. Armstrong, A. Bellingeri, A. De Mola, G. Montini, V. Scotti, A. De Silvestri, F. Campitiello","doi":"10.1002/dmrr.70248","DOIUrl":"10.1002/dmrr.70248","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Gait alterations and biomechanical changes associated with diabetic peripheral polyneuropathy have been described in the literature, but the available evidence remains fragmented. It does not provide a comprehensive overview of how the reported biomechanical patterns differ across clinical stages of the Neuropathic Diabetic Foot (NDF). Mapping these patterns may support an improved understanding of the biomechanical mechanisms underlying increased ulceration risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>This scoping review aims to explore and synthesise the existing literature on changes in gait and foot biomechanics in people with diabetes in association with Diabetic Peripheral Neuropathy (DPN) and across its reported clinical stages.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The scoping review was conducted in accordance with the JBI methodology for scoping reviews and in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The population included adults with diabetes and peripheral neuropathy, without active foot ulceration, who were managed in community or outpatient settings. The concept of interest is gait and foot-biomechanical alterations associated with diabetic neuropathy in clinical and biomechanical assessment contexts. A comprehensive search was conducted in PubMed, EMBASE, CINAHL, PEDro, and the Cochrane Library, complemented by grey literature sources including the Trip Medical Database, NICE, and the Guidelines International Network (GIN). Studies published within the last 11 years were considered (2014/12–2026/04). Data were charted and synthesised using a descriptive and narrative approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>From 2044 initial records, 44 sources met the eligibility criteria. An updated search conducted in April 2026 identified 6 additional eligible sources, resulting in 50 included sources. The evidence mapped across three principal themes: gait and lower-limb kinematic alterations, changes in plantar loading and joint kinetics, and structural or functional changes of the foot. No included study directly evaluated whether the identified biomechanical alterations predicted the subsequent development of Charcot neuro-osteoarthropathy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>To our knowledge, this is the first scoping review to map structural, kinematic, kinetic, and plantar-load","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 8","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13732642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149326480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Riccardo Maria Pollis, Federico Boscari, Damiano Furlanetto, Cristina Bittante, Maria Cristina Crepaldi, Monica Vedovato, Daniela Bruttomesso, Alberto Maran, Benedetta Maria Bonora, Mario Luca Morieri, Gian Paolo Fadini
{"title":"Diabetic Ketoacidosis at Diagnosis is Associated With Adverse Long-Term Glycaemic Trajectories and Retinopathy in Adult-Onset Type 1 Diabetes. A Single-Centre Retrospective Cohort Study","authors":"Riccardo Maria Pollis, Federico Boscari, Damiano Furlanetto, Cristina Bittante, Maria Cristina Crepaldi, Monica Vedovato, Daniela Bruttomesso, Alberto Maran, Benedetta Maria Bonora, Mario Luca Morieri, Gian Paolo Fadini","doi":"10.1002/dmrr.70249","DOIUrl":"https://doi.org/10.1002/dmrr.70249","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>The long-term significance of diabetic ketoacidosis (DKA) at the diagnosis of adult-onset type 1 diabetes (T1D) is poorly understood. We investigated the association between DKA at diagnosis and long-term outcomes.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this retrospective study, we analysed adults with T1D diagnosed at age ≥ 18 years who attended a single tertiary diabetes centre between 2000 and 2025. Participants were classified according to the presence or absence of DKA at diagnosis. Longitudinal changes in HbA1c were analysed using mixed models. Incident chronic complications were evaluated using Cox regression models.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 517 adults with T1D (47.2% women), 112 (21.7%) presented with DKA at diagnosis. The frequency of DKA at diagnosis increased from 13.2% in 2000–2008 to 34.6% after 2016 (<i>p</i> < 0.001). During a median (IQR) follow-up of 9.3 (3.5–15.5) years after cohort entry, individuals presenting with DKA had persistently higher HbA1c levels than those without DKA, with an adjusted between-group difference of 0.37% (95% CI 0.20, 0.53; <i>p</i> < 0.001). When data were aligned to the diabetes onset date, the estimated mean difference was 0.66% (<i>p</i> < 0.001). In exploratory analyses, DKA at diagnosis was associated with a higher incidence of retinopathy (HR 1.61; 95% CI 1.02–2.55; <i>p</i> = 0.041). The association was confirmed after accounting for delayed cohort entry and was attenuated by adjusting for mean HbA1c during follow-up.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Among individuals with adult-onset T1D attending a tertiary diabetes clinic, DKA at diagnosis was associated with persistently less favourable glycaemic control during long-term follow-up. Interpretation is limited by the single-centre retrospective design and delayed cohort entry.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 8","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70249","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149310861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Hessa Al-Kandari, Wafaa Al-Qabandi, Mohammed T. Hudda, Aisha Alsaqabi, Lujain D. AlAbduljaleel, Rawand Rafat Toma, Ahlam Mustafa, Fawaz Al-Refaee, Dalia Al-Abdulrazzaq
{"title":"Incidence and Associated Risk Factors of Coeliac Disease in Children Newly Diagnosed With Type 1 Diabetes: A 5-Year Nationwide Prospective Study From Kuwait","authors":"Hessa Al-Kandari, Wafaa Al-Qabandi, Mohammed T. Hudda, Aisha Alsaqabi, Lujain D. AlAbduljaleel, Rawand Rafat Toma, Ahlam Mustafa, Fawaz Al-Refaee, Dalia Al-Abdulrazzaq","doi":"10.1002/dmrr.70246","DOIUrl":"10.1002/dmrr.70246","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>Kuwait has one of the highest global incidences of childhood type 1 diabetes (T1D), yet little is known about the burden of coeliac disease (CD) in this population. We aimed to determine the prevalence/incidence of CD in children newly diagnosed with T1D in Kuwait and identify associated risk factors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>In this prospective cohort study, all 1938 children (≤ 14 years) diagnosed with T1D in Kuwait between 2011 and 2017 were enrolled and followed for 5 years post-diagnosis. CD development was defined by intestinal biopsy confirmation. Cox univariable regression models quantified associations between several characteristics at T1D diagnosis (age, sex, DKA, height z-score and BMI z-score) and incident CD risk.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Four baseline CD cases were excluded. Of the remaining 1934 children, 65 (3.4%) developed CD during follow-up. The median time to CD diagnosis was 1.5 years; 40% were diagnosed within the first year. The incidence rate within the first year following T1D diagnosis was 1.35 (95% CI 0.92–1.99) per 100 person-years and generally declined over subsequent years of follow-up. While age at diagnosis showed no clear effect shortly after T1D diagnosis, older age was associated with progressively lower CD risk over longer follow-up, with the risk of CD being 33% lower per one-year increase in age at diagnosis by 5 years of follow-up; no other baseline factors investigated were significant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This nationwide prospective study highlights the burden and timing of biopsy-confirmed CD after T1D onset. CD occurred most frequently during the early years after T1D diagnosis, with a higher risk among younger children, supporting particular attention to screening in these groups.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13715641/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149289436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Novel Paradigm for Adult-Onset Type 1 Diabetes: Once-Weekly Basal Insulin and SGLT-2 Inhibition to Harness Residual β-Cell Function","authors":"Paolo Pozzilli, Richard David Leslie","doi":"10.1002/dmrr.70247","DOIUrl":"https://doi.org/10.1002/dmrr.70247","url":null,"abstract":"<p>Type 1 diabetes (T1D) in adults is characterised by a less aggressive disease course than in children. Most patients retain preserved C-peptide (> 0<span></span><math>\u0000 <semantics>\u0000 <mrow>\u0000 <mo>.</mo>\u0000 </mrow>\u0000 <annotation> $.$</annotation>\u0000 </semantics></math>2 nmol/L) and some of them benefit from a protracted phase without the need for insulin. Here, we propose a hypothesis-generating therapeutic paradigm with once-weekly basal insulin combined with an SGLT2 inhibitor (SGLT2is) as initial therapy in T1D patients with preserved C-peptide. Once-weekly basal insulin, approved in Europe and now also in the US, confirm comparable HbA1c reductions to insulin degludec or glargine, albeit always alongside prandial insulin. SGLT2is, approved as adjuncts in T1D in select regions, can control prandial peaks without boluses. No trials have tested the combination of weekly insulin with SGLT2is in adult T1D patients. Nonetheless, the rationale is robust especially in adults with C-peptide > 0·2 nmol/L. In this respect, we urge proof-of-concept trials of 12-months randomised studies in adults ≥ 18 years, to evaluate this combination.</p>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70247","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149259354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jiao Wang, Xuan Zhou, Jiale Chen, Qingyun Wang, Xiaofei Yi, Pengbo Gao, Jingjie He, Shufen Yang, Miao Zhang, Xiaoying Sun, Liu Liu, Xin Li
{"title":"Epidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence","authors":"Jiao Wang, Xuan Zhou, Jiale Chen, Qingyun Wang, Xiaofei Yi, Pengbo Gao, Jingjie He, Shufen Yang, Miao Zhang, Xiaoying Sun, Liu Liu, Xin Li","doi":"10.1002/dmrr.70239","DOIUrl":"https://doi.org/10.1002/dmrr.70239","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aims</h3>\u0000 \u0000 <p>Diabetes mellitus (DM) is a common comorbidity of psoriatic arthritis (PsA); however, its global prevalence and the impact of treatment exposure remain unclear. This study aimed to assess the global prevalence of DM in patients with PsA using different subgroup analyses.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>A systematic search of PubMed, Embase, the Cochrane Library and the Web of Science was performed from inception until February 2025 for observational studies reporting the prevalence or incidence of DM in PsA patients. Random-effects models were applied to pool estimates, and subgroup, meta-regression, and sensitivity analyses were conducted to explore heterogeneity. Publication bias was evaluated using the Egger's test and the trim-and-fill method.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Sixty-three studies, including 293,582 patients with PsA, were analysed. Patients with PsA included in this study were divided into treatment-disclosed and non-treatment-disclosed groups. DM overall prevalence in patients with PsA was 13.84% in the non-treatment-disclosed population and 13.50% in the treatment-disclosed cohort. Geographically, the comorbidity prevalence rates were higher in South America (37.98%) and Asia (16.76%) than in Europe (12.81%) and North America (12.38%) in the non-treatment-disclosed population. In the treatment-disclosed population, prevalence was also highest in South America (28.13%), followed by Asia (18.30%). Meta-regression analysis identified age, type of DM, region, and study design as contributors to heterogeneity. Evidence of small-study effects was detected in the T2DM subgroup and cohorts receiving systemic therapy plus biologics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Subgroup analysis shows that the prevalence of DM is associated with the type of study and the region in which the patients were located. These findings support routine metabolic screening for PsA and highlight the need for longitudinal studies to track disease activity, treatment patterns, and metabolic outcomes.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70239","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149259402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exercise Modulates the Osteoimmune Axis: Myokine-Mediated Mechanisms in Diabetic Bone Disease","authors":"Chao Wu, Jun Zou, Yu Yuan","doi":"10.1002/dmrr.70245","DOIUrl":"https://doi.org/10.1002/dmrr.70245","url":null,"abstract":"<p>Patients with type 2 diabetes mellitus (T2DM) often present with normal or even elevated bone mineral density (BMD), yet exhibit a significantly increased fracture risk—a phenomenon referred to as the ‘diabetic bone paradox’. This discrepancy underscores the inadequacy of conventional BMD-centred assessment systems in fully elucidating the mechanisms underlying bone fragility in T2DM. Current evidence suggests that T2DM-related skeletal fragility is multifactorial, involving alterations in bone quality, advanced glycation end-product (AGE) accumulation, low bone turnover, microarchitectural deterioration, diabetic complications, increased fall risk and chronic inflammation. Recent advances in osteoimmunology have revealed that immune cell polarization driven by chronic low-grade inflammation, along with an imbalanced receptor activator of nuclear factor-κB ligand/osteoprotegerin (RANKL/OPG) axis, may contribute to the dysregulation of bone remodelling in T2DM. As a cornerstone intervention in T2DM management, exercise not only acts directly on bone tissue via mechanical loading but also may exert systemic immunomodulatory effects through myokines secreted by skeletal muscle. Exercise-induced myokines, such as interleukin-6 (IL-6), irisin, β-aminoisobutyric acid (BAIBA) and interleukin-15 (IL-15), may modulate the osteoimmune microenvironment and restore the dynamic equilibrium between bone resorption and formation by modulating macrophage polarization, restoring the Th17/Treg balance, bone marrow adipose tissue metabolism, and chronic inflammatory signalling pathways. Moreover, exercise may further promote bone metabolic homoeostasis by suppressing negative regulatory signals, such as myostatin. Therefore, this narrative review summarises the aberrant features of the osteoimmune axis in T2DM, with a focus on the potential mechanisms by which exercise and its induced myokines may modulate the osteoimmune microenvironment to ameliorate diabetic bone disease, thereby providing a framework for understanding exercise as a potential non-pharmacological intervention and identifying areas requiring further translational investigation.</p>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70245","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149258811","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Matteo Monami, Francesco Giorgino, Claudio Borghi, Benedetta Ragghianti, Valeria Guglielmi, Paolo Sbraccia
{"title":"Pre-Obesity and Preclinical Obesity: Disease-Specific Concepts or Generalisable Frameworks for Chronic Disease Classification?","authors":"Matteo Monami, Francesco Giorgino, Claudio Borghi, Benedetta Ragghianti, Valeria Guglielmi, Paolo Sbraccia","doi":"10.1002/dmrr.70238","DOIUrl":"10.1002/dmrr.70238","url":null,"abstract":"<p>The Lancet Commission on Clinical Obesity proposes a distinction between conditions that primarily represent future health risk and those that constitute established illness. Its separation of pre-obesity, preclinical obesity and clinical obesity provides a useful framework for discussing the relationship between adiposity, disease definition and disease staging [<span>1</span>].</p><p>At a conceptual level, the Commission describes three states. Pre-obesity refers to a condition associated with increased future risk but not yet meeting criteria for obesity. Preclinical obesity refers to individuals who already meet obesity criteria but have not developed obesity-related organ dysfunction, clinical manifestations or limitations in activities of daily living. Clinical obesity is defined by the presence of such consequences [<span>1</span>].</p><p>Although this framework was developed for obesity, its underlying logic is not unique. Many chronic diseases can be viewed as progressing through a risk stage, a biologically defined disease stage without clinically evident consequences and a stage characterised by organ dysfunction and/or complications. Importantly, using diabetes and hypertension as comparators does not imply biological or nosological equivalence with obesity. Rather, these conditions provide a conceptual benchmark against which the strengths and limitations of the proposed distinction between risk, preclinical disease and clinical disease can be examined.</p><p>Current classifications of diabetes and hypertension already recognise risk states that precede disease. Prediabetes identifies individuals with glycaemic values above the normal range but below accepted diagnostic thresholds for diabetes mellitus (HbA1c 5.7%–6.4% [42–47 mmol/mol]) [<span>2</span>]. Similarly, elevated (or high-normal) blood pressure (120–139/70–89 mmHg) identifies individuals at increased cardiovascular risk who do not yet meet diagnostic criteria for hypertension [<span>3</span>].</p><p>If the Commission's framework were applied consistently to these conditions, an intermediate category would emerge after diagnostic thresholds are crossed but before complications develop. Individuals with diabetes who have no retinopathy, nephropathy, neuropathy or functional impairment could be described as having preclinical diabetes. Likewise, individuals with hypertension but without hypertension-mediated organ damage could be considered to have preclinical hypertension.</p><p>Under such a model, disease progression would involve three stages: a risk state (prediabetes or prehypertension), a biologically defined disease state without clinically manifest consequences (preclinical diabetes or preclinical hypertension) and a disease state with established complications (clinical diabetes or clinical hypertension). In this sense, the distinction between preclinical and clinical disease is potentially generalisable rather than obesity-specific. However, such conceptual gener","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13689525/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149247156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francesca Gatti, Bianca M. Milazzo, Lauren M. Quinn, Antonio Catarinella, Gaia Perego, Francesca Milano, Karin Lange, Sheila Greenfield, Renuka Dias, Jurgen Vercauteren, Adya Rao, Aymeric Mahieu, Carmen Hurtado del Pozo, Valentina E. Di Mattei, Katharine Barnard, Chantal Mathieu, Parth Narendran, Emanuele Bosi, Olga Boiko, EDENT1FI
{"title":"Professional Stakeholders' Perspectives on Early Screening for Type 1 Diabetes in Children: A Systematic Review","authors":"Francesca Gatti, Bianca M. Milazzo, Lauren M. Quinn, Antonio Catarinella, Gaia Perego, Francesca Milano, Karin Lange, Sheila Greenfield, Renuka Dias, Jurgen Vercauteren, Adya Rao, Aymeric Mahieu, Carmen Hurtado del Pozo, Valentina E. Di Mattei, Katharine Barnard, Chantal Mathieu, Parth Narendran, Emanuele Bosi, Olga Boiko, EDENT1FI","doi":"10.1002/dmrr.70240","DOIUrl":"10.1002/dmrr.70240","url":null,"abstract":"<p>Early screening for type 1 diabetes (T1D) is receiving increasing attention as presymptomatic screening initiatives and disease-modifying therapies continue to expand. However, the perspectives of professional stakeholders, who play a pivotal role in implementation, patient engagement, and health system preparedness, have not been systematically synthesised. We conducted a systematic review to examine professional views on paediatric early T1D screening. Following PRISMA guidelines, six databases (Medline, Embase, Scopus, CINAHL, PsycINFO, ASSIA) and grey literature were searched through January 2026. Twelve studies met the inclusion criteria, predominantly involving paediatricians and diabetes specialists; nurses, genetic counsellors, policymakers, and other healthcare professionals were represented in few studies. Methodological appraisal using the Mixed Methods Appraisal Tool (MMAT) identified recurring limitations in sample representativeness and potential nonresponse bias. Given the heterogeneity and primarily descriptive nature of the study design and outcomes, findings were synthesised narratively. Professional perspectives varied according to the population targeted, professional group studied, screening scenario, and the implementation context. Where directly compared, support was greater for at-risk than for general-population screening. Reported benefits included diabetic ketoacidosis (DKA) prevention, earlier clinical engagement, and improved preparedness for families. However, concerns persisted regarding psychosocial burden, workforce capacity, and unclear referral and follow-up pathways. More favourable evaluations were reported in some structured programmes, although these findings may reflect reliance on existing infrastructures and targeted participant selection. By consolidating previously fragmented evidence, this review identifies recurring clinical, psychosocial, and organisational considerations relevant to paediatric T1D screening. These findings primarily reflect clinical perspectives and indicate conditional rather than uniform support. Further studies should evaluate how standardised pathways, professional training, and integrated psychosocial support affect the feasibility and acceptability of screening across different healthcare contexts.</p>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13679756/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149225246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jonah J. C. Thomas, Anna Meffen, Alessandro Rizzi, Andrew P. Kingsnorth, Beatrice Pieri, Ying He, Shirley Konnor, Clare Gillies, Kamlesh Khunti, Jonathan Valabhji, Shivani Misra, Amanda Adler, Christian Torp-Pedersen, Martina Vettoretti, Julia K. Mader, Pratik Choudhary
{"title":"Real-World Databases in Diabetes: A Systematic Review","authors":"Jonah J. C. Thomas, Anna Meffen, Alessandro Rizzi, Andrew P. Kingsnorth, Beatrice Pieri, Ying He, Shirley Konnor, Clare Gillies, Kamlesh Khunti, Jonathan Valabhji, Shivani Misra, Amanda Adler, Christian Torp-Pedersen, Martina Vettoretti, Julia K. Mader, Pratik Choudhary","doi":"10.1002/dmrr.70241","DOIUrl":"10.1002/dmrr.70241","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Aim</h3>\u0000 \u0000 <p>To identify publications that describe RWD databases in the field of diabetes and map their key characteristics.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Databases were searched (MEDLINE, SCOPUS, CINAHL from January 2018 to October 2025) to identify relevant publications describing RWD databases. Eligible studies were identified as RWD databases that contained more than 1000 adults and were followed up for one year or longer. Metadata including population, sample size, and outcomes were then extracted.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 610 eligible RWD databases were identified from 1779 included articles. Databases were identified in 74 countries, with the majority collected in Europe (<i>n</i> = 193). Only 22 databases were identified in lower- and- middle income countries (as defined by the World Bank). Demographics, prescription, diagnosis, and biochemical information were collected frequently; however, mortality and technology related variables (CGM usage) were found in fewer datasets. Very few databases were open access however 205 mentioned having the possibility for data sharing.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>We have produced an online dashboard to summarise the RWD databases available in the field of diabetes. We found many RWD databases globally that contain a range of variables related to individuals' health; however, lower- and middle-income nations are underrepresented within these data.</p>\u0000 </section>\u0000 </div>","PeriodicalId":11335,"journal":{"name":"Diabetes/Metabolism Research and Reviews","volume":"42 7","pages":""},"PeriodicalIF":8.3,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.70241","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149197235","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}